Clinical Trial Update: Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial exploring Envafolimab in combination with Endostar and chemotherapy as first-line treatment for advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)
• Envafolimab (envafolimab)

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: UNKNOWN